Xtl Biopharmaceuticals (XTLB) FCF Margin Growth (1y) (2012 - 2014)
Xtl Biopharmaceuticals (XTLB) FCF Margin Growth (1y) (2012 - 2014) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 172.00 |
| Jun 30, 2014 | -1,203.00 |
| Mar 31, 2014 | -5,377.00 |
| Dec 31, 2013 | 517.00 |
| Sep 30, 2013 | -2,323.00 |
| Jun 30, 2013 | -6,854.00 |
| Mar 31, 2013 | -3,726.00 |
| Dec 31, 2012 | -9,910.00 |
| Sep 30, 2012 | -9,052.00 |
| Jun 30, 2012 | -2,024.00 |